PJ view: ADHD care is coming to primary care and pharmacists must be written into the plan

A government review recommends shifting long-term ADHD care to primary care, with specialists handling complex cases and medication initiation, emphasizing the strong evidence base for medication over psychosocial treatments. The review highlights challenges in transitioning from diagnosis to treatment, with declining medication uptake and low GP acceptance of shared care. Despite pharmacists' potential role in ADHD management, they are scarcely mentioned in the review, despite successful examples where pharmacists have improved medication management and reduced consultant workload.

Read at The Pharmaceutical Journal

All articles from 22 October 2026. Summaries are AI-generated and may contain errors; the linked article is the authority.